Korean industry
Health Care Equipment & Supplies
90 stocks · Calculated by ChickenStock
- 1
HLB028300₩6.31T
- 2
PharmaResearch214450₩3.18T
- 3
CLASSYS214150₩2.05T
- 4
L&C Bio290650₩1.41T
- 5
LivsMed491000₩969.8B
- 6
SD Biosensor137310₩776.4B
- 7
InBody041830₩705.1B
- 8
HLB Life Science067630₩545B
- 9
376900376900₩499.8B
- 10
i-SENS099190₩496.2B
- 11
BioNote377740₩472.8B
- 12
340570340570₩461.2B
- 13
336570336570₩459.8B
- 14
0120G00120G0₩376.3B
- 15
060280060280₩371.3B
- 16
145720145720₩348B
- 17
455900455900₩345.6B
- 18
042520042520₩317.3B
- 19
228760228760₩303.3B
- 20
054950054950₩293.8B
- 21
100120100120₩266B
- 22
043150043150₩261.7B
- 23
389650389650₩260.7B
- 24
108860108860₩252.7B
- 25
450950450950₩240.1B
- 26
099430099430₩233.3B
- 27
216080216080₩228.6B
- 28
256840256840₩218.2B
- 29
314930314930₩203B
- 30
041920041920₩191B
- 31
138610138610₩188.4B
- 32
119610119610₩187.6B
- 33
318060318060₩178.6B
- 34
179290179290₩150.3B
- 35
0088M00088M0₩149.2B
- 36
387690387690₩149.1B
- 37
156100156100₩141B
- 38
048870048870₩140.4B
- 39
228850228850₩137.5B
- 40
240550240550₩134.6B
- 41
004080004080₩133.5B
- 42
039840039840₩133.5B
- 43
056090056090₩122.9B
- 44
059210059210₩102.3B
- 45
100700100700₩102.1B
- 46
246720246720₩99.4B
- 47
394420394420₩96.7B
- 48
303810303810₩89.7B
- 49
006140006140₩87.3B
- 50
226400226400₩86.8B
- 51
142280142280₩79.3B
- 52
302550302550₩77.7B
- 53
104540104540₩77.4B
- 54
253840253840₩76.6B
- 55
149980149980₩76.5B
- 56
065510065510₩76B
- 57
303360303360₩75.1B
- 58
460940460940₩72.1B
- 59
234920234920₩71.8B
- 60
208370208370₩71.2B
Market cap: official daily values from the Korea Exchange (KRX) · Top 60 shown · Stocks without a value (losses, not reported) are listed last · For reference only; not investment advice.
Health Care Equipment & Supplies in Korea at a glance
There are 90 listed companies in the Health Care Equipment & Supplies industry in Korea. By market cap, the largest are HLB (₩6.31T), PharmaResearch (₩3.18T), CLASSYS (₩2.05T). By latest annual operating margin, the highest are CLASSYS (50.7%), PharmaResearch (40%), InBody (15.7%). Switch the metric in the table above to rank by market cap, revenue, operating margin or P/E. (As of Oct 7, 2026 · market cap: official KRX values; financials calculated by ChickenStock from filings · for reference only, not investment advice)